Pill reduced number of multiple sclerosis lesions in Phase II trial
Monday, April 16, 2012 - 21:30
in Health & Medicine
An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis, according to the results of a phase two clinical trial.